Johannes M W van den Ouweland1, Antonius M Beijers2, Henny van Daal2. 1. Department of Clinical Chemistry, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands. Electronic address: j.v.d.ouweland@cwz.nl. 2. Department of Clinical Chemistry, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Abstract
BACKGROUND: An LC-MS/MS method was developed for simultaneous quantification of 25-hydroxyvitamin D3 (25(OH)D3), 3-epi-25(OH)D3, and 25(OH)D2 in human serum. METHODS: Sample preparation consisted of protein precipitation followed by off-line SPE. Calibration curves for each vitamin D metabolite were constructed in phosphate-buffered saline with 60 g/L albumin including its corresponding stable isotope labelled (SIL) internal standard. A pentafluorophenyl (PFP) analytical column was used to resolve 25(OH)D3 from 25(OH)D2 and 3-epi-25(OH)D3, followed by SRM registration using positive ESI-MS/MS. Accuracy was assessed from measurement of samples with NIST reference method procedure (RMP) assigned values. The PFP LC-MS/MS method was compared to an in-house C18 column LC-MS/MS method, not resolving 25(OH)D3 from 3-epi-25(OH)D3, using adult and newborn samples. RESULTS: Intra-assay and inter-assay coefficients of variation were less than 4% and 7.5%, respectively for all three vitamin D metabolites; lower limits of quantification were 1, 1 and 2 nmol/L and linearity of methods were 1-500, 1-200 and 2-500 nmol/L for 25(OH)D3, 3-epi-25(OH)D3 and 25(OH)D2, respectively. The PFP LC-MS/MS method showed minimal bias to the NIST RMP. Method comparison revealed that in the C18 LC-MS/MS method, the 3-epi-25(OH)D3 concentration is overestimated inadvertently not only from co-elution of both analytes, but also by an additional 30-40% higher ionisation efficiency of 3-epi-25(OH)D3 when compared to 25(OH)D3. CONCLUSION: This accurate LC-MS/MS method allows the simultaneous measurement of 25(OH)D3, 3-epi-25(OH)D3, and 25(OH)D2 in human serum. Due to increased ionisation efficiency, the contribution of the 3-epi-25(OH)D3 metabolite to the total 25(OH)D3 concentration is significantly overestimated in MS methods that do not resolve 3-epi-25(OH)D3 from 25(OH)D3 and may compromise its use in infant samples known to have significant amounts of 3-epi-25(OH)D3.
BACKGROUND: An LC-MS/MS method was developed for simultaneous quantification of 25-hydroxyvitamin D3 (25(OH)D3), 3-epi-25(OH)D3, and 25(OH)D2 in human serum. METHODS: Sample preparation consisted of protein precipitation followed by off-line SPE. Calibration curves for each vitamin D metabolite were constructed in phosphate-buffered saline with 60 g/L albumin including its corresponding stable isotope labelled (SIL) internal standard. A pentafluorophenyl (PFP) analytical column was used to resolve 25(OH)D3 from 25(OH)D2 and 3-epi-25(OH)D3, followed by SRM registration using positive ESI-MS/MS. Accuracy was assessed from measurement of samples with NIST reference method procedure (RMP) assigned values. The PFP LC-MS/MS method was compared to an in-house C18 column LC-MS/MS method, not resolving 25(OH)D3 from 3-epi-25(OH)D3, using adult and newborn samples. RESULTS: Intra-assay and inter-assay coefficients of variation were less than 4% and 7.5%, respectively for all three vitamin D metabolites; lower limits of quantification were 1, 1 and 2 nmol/L and linearity of methods were 1-500, 1-200 and 2-500 nmol/L for 25(OH)D3, 3-epi-25(OH)D3 and 25(OH)D2, respectively. The PFP LC-MS/MS method showed minimal bias to the NIST RMP. Method comparison revealed that in the C18 LC-MS/MS method, the 3-epi-25(OH)D3 concentration is overestimated inadvertently not only from co-elution of both analytes, but also by an additional 30-40% higher ionisation efficiency of 3-epi-25(OH)D3 when compared to 25(OH)D3. CONCLUSION: This accurate LC-MS/MS method allows the simultaneous measurement of 25(OH)D3, 3-epi-25(OH)D3, and 25(OH)D2 in human serum. Due to increased ionisation efficiency, the contribution of the 3-epi-25(OH)D3 metabolite to the total 25(OH)D3 concentration is significantly overestimated in MS methods that do not resolve 3-epi-25(OH)D3 from 25(OH)D3 and may compromise its use in infant samples known to have significant amounts of 3-epi-25(OH)D3.
Authors: Karen W Phinney; Johanna E Camara; Susan S-C Tai; Lane C Sander; Stephen A Wise; Linde A C De Grande; Linda M Thienpont; Antonio M Possolo; Blaza Toman; Christopher T Sempos; Joseph M Betz; Paul M Coates Journal: J AOAC Int Date: 2017-06-16 Impact factor: 1.913
Authors: Timon Geib; Lekha Sleno; Rabea A Hall; Caroline S Stokes; Dietrich A Volmer Journal: J Am Soc Mass Spectrom Date: 2016-05-06 Impact factor: 3.109
Authors: Karen W Phinney; Susan S-C Tai; Mary Bedner; Johanna E Camara; Rosalind R C Chia; Lane C Sander; Katherine E Sharpless; Stephen A Wise; James H Yen; Rosemary L Schleicher; Madhulika Chaudhary-Webb; Khin L Maw; Yasamin Rahmani; Joseph M Betz; Joyce Merkel; Christopher T Sempos; Paul M Coates; Ramón A Durazo-Arvizu; Kurtis Sarafin; Stephen P J Brooks Journal: Anal Chem Date: 2017-04-13 Impact factor: 6.986
Authors: Christopher D Chouinard; Vinícius Wilian D Cruzeiro; Christopher R Beekman; Adrian E Roitberg; Richard A Yost Journal: J Am Soc Mass Spectrom Date: 2017-04-17 Impact factor: 3.109
Authors: Christopher D Chouinard; Vinicius Wilian D Cruzeiro; Robin H J Kemperman; Nicholas R Oranzi; Adrian E Roitberg; Richard A Yost Journal: Int J Mass Spectrom Date: 2018-05-22 Impact factor: 1.986
Authors: Niek F Dirks; Hubert W Vesper; Antonius E van Herwaarden; Jody M W van den Ouweland; Ido P Kema; Johannes G Krabbe; Annemieke C Heijboer Journal: Clin Chim Acta Date: 2016-08-25 Impact factor: 3.786
Authors: Nina Ooms; Henny van Daal; Antonius M Beijers; G Peter J M Gerrits; Ben A Semmekrot; Johannes M W van den Ouweland Journal: Pediatr Res Date: 2015-12-28 Impact factor: 3.756
Authors: Brian C DeFelice; Theresa L Pedersen; Hanan Shorrosh; Randi K Johnson; Jennifer A Seifert; Jill M Norris; Oliver Fiehn Journal: J Steroid Biochem Mol Biol Date: 2019-11-10 Impact factor: 4.292